Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

May 15, 2013

30339_dirs_2013-05-15_524fb698-9cca-4d07-bced-d0eddba571ae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-19 Common Stock A 490.0000 $59.1100 Acquired 7580.1040 Direct

Footnotes

F1: Bonus and incentive shares granted on 02/19/2013.